Cogene Ventures

Cogene Ventures, a Texas-based venture capital firm, specializes in early-, mid-, expansion-, and late-stage investments.

Number of Investments

Number of Lead Investments

8

0

Cogene Ventures has made 8 investments. Their most recent investment was on Mar 8, 2006, when Neuromed Pharmaceuticals raised $25M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Mar 8, 2006 Neuromed Pharmaceuticals	Series D	$25M	Biopharma	—
Oct 24, 2005 Raven Biotechnologies	Series D	$48.30M	Biotechnology	—
Oct 15, 2004 MacroGenics	Series B	$30.50M	Biotechnology	—
Jun 23, 2004 Rejuvenon	Series B	$37M	Biotechnology	—
Mar 1, 2004 TransMolecular	Series C	$33.20M	Biotechnology	—

Cogene Ventures has had 5 exits. Cogene Ventures most notable exits include MacroGenics , TransMolecular

Date	Company Name	Exit Type	Industry
Oct 10, 2013	MacroGenics	IPO	Biotechnology	Detail
Mar 4, 2011	TransMolecular	M&A	Biotechnology	Detail
Dec 21, 2009	Neuromed Pharmaceuticals	M&A	Biopharma	Detail
Jul 17, 2008	Raven Biotechnologies	M&A	Biotechnology	Detail
Apr 21, 2006	Catalyst Bioscience	IPO	Biotechnology	Detail